Pyrimidine compounds as kinase inhibitors
作者： M V Ramana Reddy , E Premkumar Reddy
DOI:
关键词: Cancer 、 Pyrimidine 、 Biochemistry 、 Chemistry 、 Kinase
摘要: This disclosure relates to compounds, methods for their preparation, pharmaceutical compositions including these compounds and the treatment of cellular proliferative disorders, including, but not limited to, cancer.
lens.org 参考文章(24)
Paul Knochel, Gary A. Molander, Comprehensive organic synthesis Elsevier. ,(2014)
Jeremy Robertson, Protecting Group Chemistry ,(2000)
Wendy Anne GlaxoSmithKline Knight, Simon Joseph GlaxoSmithKline Holland, Graham Stanley GlaxoSmithKline Leonard, Wet milling process ,(2001)
Ellen Myra Dobrusin, Dennis Joseph Mcnamara, Richard John Booth, Peter Laurence Toogood, Vara Prasad Venkata Nagendra Josyula, Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors ,(2001)
Masataka Hikota, Kohei Kikkawa, Kenji Omori, Koichiro Yamada, Yuichi Koga, Pyridopyrimidine or naphthyridine derivative ,(2002)
Michael B. Smith, March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure ,(2007)
Alfonso R. Gennaro, Joseph P. Remington, Remington's pharmaceutical sciences Published in <b>1975</b> in Easton Pa) by Mack. ,(1985)
Richard C. Larock, Comprehensive organic transformations : a guide to functional group preparations Wiley-VCH. ,(2018) , 10.1002/9781118662083
Thomas Charles Malone, Richard John Booth, Arindam Chatterjee, Pyridopyrimidinone derivatives for treatment of neurodegenerative disease ,(2000)
Otto Meth-Cohn, Alan R. Katritzky, Charles W. Rees, Comprehensive organic functional group transformations II Pergamon , Elsevier Science. ,(1995)